Smith & Nephew PLC 6-K, filed Jun 21, 2022
Smith & Nephew PLC (SNN)
6-K
2022-06-21
For: 2022-06-21
View Original
Added on
April 07, 2026
About this 6-K
Smith & Nephew PLC filed this 6-K on June 21, 2022.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
June 20,
2022
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant's
name)
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
(Address
of registrant's principal executive offices)
[Indicate
by check mark whether the registrant files or will file
annual
reports
under cover Form 20-F or Form 40-F.]
Form
20-F
X
Form 40-F
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(1).]
Yes
No X
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(7).]
Yes
No X
---
---
[Indicate
by check mark whether by furnishing the information
contained
in this
Form, the registrant is also thereby furnishing information to
the
Commission
pursuant to Rule 12g3-2 (b) under the Securities Exchange Act
of
1934.]
Yes
No X
---
---
If
"Yes" is marked, indicate below the file number assigned to
the
registrant
in connection with Rule 12g3-2 (b) : 82- n/a.
20 June 2022
Smith+Nephew announces new Senior Independent Director
Smith & Nephew plc (LSE:SN, NYSE:SNN) announces that Robin
Freestone has
decided to step
down as Senior Independent Director and as a Non-Executive Director
of Smith & Nephew plc with effect from 30 September 2022. Marc
Owen, Non-Executive Director, will be appointed as Senior
Independent Director with effect from the same
date.
Mr Freestone was appointed as a Non-Executive Director in September
2015 and subsequently appointed as Senior Independent Director in
April 2019. Mr Owen was appointed as a Non-Executive Director in
October 2017. In addition to his appointment as Senior Independent
Director, Mr Owen will continue in his role as Chair of the
Compliance & Culture Committee and as a member of the Audit
Committee and Nomination & Governance Committee. He will take
over from Mr Freestone in leading the search for a new Chair of the
company.
The Board would like to thank Mr Freestone for his commitment and
contribution to the Board and the Company and to congratulate Mr
Owen on his new appointment.
Enquiries
|
|
|
|
Investors
|
|
|
Andrew Swift
|
+44 (0) 1923 477433
|
|
Smith+Nephew
|
|
|
|
|
|
Media
|
|
|
Charles Reynolds
|
+44 (0) 1923 477314
|
|
Smith+Nephew
|
|
|
|
|
|
Susan Gilchrist / Ayesha Bharmal
|
+44 (0) 20 7404 5959
|
|
Brunswick
|
|
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on
the repair, regeneration and replacement of soft and hard tissue.
We exist to restore people's bodies and their self-belief by using
technology to take the limits off living. We call this purpose
'Life Unlimited'. Our
18,000 employees deliver this mission every day, making a
difference to patients' lives through the excellence of our
product portfolio, and the invention and application of new
technologies across our three global franchises of
Orthopaedics, Sports Medicine & ENT and Advanced Wound
Management.
Founded in Hull, UK, in 1856, we now operate in more than 100
countries, and generated annual sales of $5.2 billion in 2021.
Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN).
The terms 'Group' and 'Smith+Nephew' are used to refer to Smith
& Nephew plc and its consolidated subsidiaries, unless the
context requires otherwise.
For more information about Smith+Nephew, please
visit www.smith-nephew.com and
follow us on Twitter, LinkedIn, Instagram or Facebook.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Smith
& Nephew Plc
(Registrant)
Date: June
20, 2022
By: /s/
Helen Barraclough
-----------------
Helen
Barraclough
Company
Secretary